Cresset Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Buy
6,893
+788
+13% +$40K ﹤0.01% 1324
2026
Q1
$326K Buy
6,105
+1,375
+29% +$80.7K ﹤0.01% 1236
2025
Q4
$294K Hold
4,730
﹤0.01% 1307
2025
Q3
$284K Buy
4,730
+342
+8% +$20.9K ﹤0.01% 1269
2025
Q2
$275K Sell
4,388
-486
-10% -$29.2K ﹤0.01% 1167
2025
Q1
$293K Hold
4,874
﹤0.01% 1328
2024
Q4
$284K Sell
4,874
-688
-12% -$40.9K ﹤0.01% 1381
2024
Q3
$329K Buy
5,562
+846
+18% +$48.3K ﹤0.01% 1756
2024
Q2
$264K Sell
4,716
-207
-4% -$11.6K ﹤0.01% 1774
2024
Q1
$288K Sell
4,923
-1,322
-21% -$74.7K ﹤0.01% 1607
2023
Q4
$337K Buy
6,245
+1,030
+20% +$50.3K ﹤0.01% 1430
2023
Q3
$254K Buy
5,215
+56
+1% +$2.98K ﹤0.01% 1508
2023
Q2
$291K Buy
+5,159
New +$284K ﹤0.01% 1534
2022
Q2
Sell
-3,688
Closed -$225K 1015
2022
Q1
$225K Buy
+3,688
New +$220K ﹤0.01% 876
2019
Q2
Sell
-762
Closed -$29K 1029
2019
Q1
$29K Buy
+762
New +$27.7K ﹤0.01% 938

Other funds holding IHI

Cresset Asset Management's IHI Position: Q2 2026 in Review

Cresset Asset Management increased its iShares US Medical Devices ETF (IHI) stake by 13% in Q2 2026, buying an estimated $40K and bringing the position to 6,893 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Cresset Asset Management first reported a position in IHI in Q1 2019 and has held it in 15 quarters since. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Cresset Asset Management held 6,893 shares of iShares US Medical Devices ETF worth $341K as of Q2 2026.
  • Cresset Asset Management bought 788 iShares US Medical Devices ETF shares in Q2 2026, an estimated $40K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1324 holding.
  • Cresset Asset Management first reported a position in iShares US Medical Devices ETF in Q1 2019 and has held it in 15 quarters since.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.